Characterization of the effects of lithium and inositol on phosphoinositide turnover in cerebellar granule cells in primary culture.
The effect of lithium on inositol phospholipid resynthesis in primary cultures of cerebellar granule cells was studied. During activation of phospholipase C by the combined action of a muscarinic agonist and mild depolarization, the levels of inositol phospholipids as well as the inositol phospholipid precursor CMP-phosphatidate appeared highly sensitive to lithium with half-maximal accumulation of CMP-phosphatidate attained at 0.5 mM LiCl, a concentration close to that in the plasma of patients subjected to lithium therapy. Under the same conditions, the effect of lithium on inositol phospholipid metabolism appeared to be mediated by depletion of cytoplasmic free inositol content. This was indicated by the observation that preincubation for 48 h in high extracellular inositol concentrations could decrease or delay the depletion of inositol phospholipids and the accumulation of CMP-phosphatidate induced by 10 mM LiCl. Because even relatively high concentrations of extracellular inositol (500 microM) only partially prevented inositol phospholipid depletion, cerebellar granule cells appear to have a comparatively low capacity to accumulate inositol intracellularly, in comparison with other brain cells in culture. The relationship between CMP-phosphatidate accumulation and phospholipase C activity has also been investigated using a range of agonists that have been reported to act on cerebellar granule cells.
del Río
E
E
Pharmacology Department, Ninewells Medical School, Dundee, Scotland.
Nicholls
D G
DG
Downes
C P
CP
D000818:Animals; D002478:Cells, Cultured; D002531:Cerebellum / Q000166:cytology / Q000378:metabolism*; D003568:Cytidine Monophosphate / Q000819:agonists / Q000031:analogs & derivatives / Q000378:metabolism; D005110:Extracellular Space / Q000378:metabolism; D020404:Glycerophospholipids; D007294:Inositol / Q000378:metabolism / Q000494:pharmacology*; D008094:Lithium / Q000494:pharmacology*; D018021:Lithium Chloride / Q000494:pharmacology; D009474:Neurons / Q000378:metabolism*; D010712:Phosphatidic Acids / Q000819:agonists / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism*; D051381:Rats
D020404:Glycerophospholipids; D010712:Phosphatidic Acids; D010716:Phosphatidylinositols; C088379:cytidine monophosphorylphosphatidate; D007294:Inositol; D008094:Lithium; D003568:Cytidine Monophosphate; D018021:Lithium Chloride